SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zajicek, J
Right arrow Articles by Compston, A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zajicek, J
Right arrow Articles by Compston, A
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Mechanisms of damage and repair in multiple sclerosis — a review

J Zajicek

University of Cambridge Neurology Unit, Addenbrooke's Hospital, Hill's Road, Cambridge CB2 2QQ, UK

A Compston

University of Cambridge Neurology Unit, Addenbrooke's Hospital, Hill's Road, Cambridge CB2 2QQ, UK

Pathological features of MS include perivascular inflammation and demyelination with oligodendrocyte loss; in addition, attempts at remyelination are of ten unsuccessful and may culminate in astrocytic scarring. One approach to investigating the biological principles underlying these processes is to use in vitro systems to analyse single-cell behaviour as well as cell-cell interactions. This paper reviews such data concerned with cell injury and repair which illuminate both demyelination and remyelination. In tissue culture oligodendrocytes are susceptible to injury via cell-mediated and humoral mechanisms. Substances including complement and tumour necrosis factor are capable of killing rat oligodendrocytes in vitro; surface complement activation also initiates a number of intracellular processes within oligodendrocytes as well as providing ligands for phagocytic interactions. The reasons for oligodendrocyte complement activation are discussed, but it appears that species differences exist when extrapolating these data to humans. Myelination and remyelination can also be studied both in vitro and in vivo using defined cell populations. Results from these studies may eventually help to explain some pathological features of MS, including astrocytosis and factors governing the limits of remyelination.

Key Words: inflammation • complement • tumour necrosis factor • myelination • astrocytosis

Multiple Sclerosis, Vol. 1, No. 2, 61-72 (1995)
DOI: 10.1177/135245859500100202


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. E. Jones, T. Kay, T. Keller, and D. Bourdette
Nonmyelin-Specific T Cells Accelerate Development of Central Nervous System APC and Increase Susceptibility to Experimental Autoimmune Encephalomyelitis
J. Immunol., January 15, 2003; 170(2): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
H. d. F Webster
Growth factors and myelin regeneration in multiple sclerosis
Multiple Sclerosis, April 1, 1997; 3(2): 113 - 120.
[Abstract] [PDF]



Advertisement